BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37052075)

  • 1. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 11.
    Bray B; Ramagopalan SV
    J Comp Eff Res; 2023 May; 12(5):e230008. PubMed ID: 37052075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14.
    Bray BD; Ramagopalan SV
    J Comp Eff Res; 2024 Jan; 13(1):e230189. PubMed ID: 38179957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2022 May; 11(7):473-475. PubMed ID: 35261285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2022 Nov; 11(16):1147-1149. PubMed ID: 35998008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2022 Sep; 11(13):915-917. PubMed ID: 35703134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.
    Castanon A; Bray BD; Ramagopalan SV
    J Comp Eff Res; 2024 May; 13(5):e240033. PubMed ID: 38546012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2023 Jan; 12(1):e220194. PubMed ID: 36453665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13.
    Bray BD; Ramagopalan SV
    J Comp Eff Res; 2023 Nov; 12(11):e230141. PubMed ID: 37712636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12.
    Bray B; Ramagopalan SV
    J Comp Eff Res; 2023 Jul; 12(7):e230092. PubMed ID: 37345541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2022 Mar; 11(4):213-215. PubMed ID: 34989244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2021 Jul; 10(10):797-799. PubMed ID: 33955236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 4.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2022 Jan; 11(1):11-12. PubMed ID: 34702048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 3.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2021 Nov; 10(16):1175-1176. PubMed ID: 34412538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 7.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2022 Jul; 11(10):699-701. PubMed ID: 35506497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2.
    Simpson A; Ramagopalan SV
    J Comp Eff Res; 2021 Sep; 10(13):957-959. PubMed ID: 34184540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
    Wang SV; PottegÄrd A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ
    Value Health; 2022 Oct; 25(10):1663-1672. PubMed ID: 36241338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
    Wang SV; PottegÄrd A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ
    Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):44-55. PubMed ID: 36215113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building trust in real world evidence (RWE): moving transparency in RWE towards the randomized controlled trial standard.
    White R
    Curr Med Res Opin; 2023 Dec; 39(12):1737-1741. PubMed ID: 37787381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.
    Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD
    Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.